Home GPCR & G Protein -Endocrinology & Hormones GNRH Receptor

GNRH Receptor

GNRH Receptor Products

  • All (2)
  • GNRH Receptor Antagonists (2)
  • New GNRH Receptor Products
Catalog No. Product Name Information Product Use Citations Product Validations
S4896 Elagolix Sodium Elagolix Soidum (NBI-56418, ABT-620) is a potent, selective, orally active, non-peptide antagonist of the gonadotropin-releasing hormone receptor (GnRHR) with Kd value of 54 pM. Concentration at 10 μM shows no significant activity on ion channels, enzymes, and transporters (inhibition <50%).
iScience, 2023, 26(5):106749
J Int Med Res, 2022, 50(3):3000605221082895
Nat Commun, 2020, 11(1):5287
S5808 Relugolix Relugolix (RVT-601, TAK-385) is a selective antagonist of the gonadotropin-releasing hormone receptor (GnRHR) with IC50 of 0.33 nM and 0.32 nM for human GnRHR and monkey GnRHR, respectively.
iScience, 2024, 27(10):110862
S4896 Elagolix Sodium Elagolix Soidum (NBI-56418, ABT-620) is a potent, selective, orally active, non-peptide antagonist of the gonadotropin-releasing hormone receptor (GnRHR) with Kd value of 54 pM. Concentration at 10 μM shows no significant activity on ion channels, enzymes, and transporters (inhibition <50%).
iScience, 2023, 26(5):106749
J Int Med Res, 2022, 50(3):3000605221082895
Nat Commun, 2020, 11(1):5287
S5808 Relugolix Relugolix (RVT-601, TAK-385) is a selective antagonist of the gonadotropin-releasing hormone receptor (GnRHR) with IC50 of 0.33 nM and 0.32 nM for human GnRHR and monkey GnRHR, respectively.
iScience, 2024, 27(10):110862

Choose Selective GNRH Receptor Inhibitors

Tags: GNRH Receptor inhibitor|GNRH Receptor agonist|GNRH Receptor activator|GNRH Receptor inducer|GNRH Receptor antagonist|GNRH Receptor signaling pathway|GNRH Receptor assay kit